Deutsche Bank’s HOOKIPA Pharma HOOK Stock Holding History

Deutsche Bank’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,028	Closed	-$274K	–	4208
2022 Q1	$274K	Sell	12,028 -124	-1%	-$2.22K	﹤0.01%	3074
2021 Q4	$283K	Buy	12,152 +62	+0.5%	+$2.49K	﹤0.01%	3183
2021 Q3	$713K	Sell	12,090 -36	-0.3%	-$2.61K	﹤0.01%	2823
2021 Q2	$1.11M	Buy	12,126 +11,278	+1,330%	+$1.5M	﹤0.01%	2702
2021 Q1	$114K	Sell	848 -77	-8%	-$9.29K	﹤0.01%	3909
2020 Q4	$103K	Buy	925 +249	+37%	+$26.9K	﹤0.01%	3834
2020 Q3	$64K	Buy	676 +60	+10%	+$6.12K	﹤0.01%	3757
2020 Q2	$71K	Buy	616 +260	+73%	+$25.3K	﹤0.01%	3630
2020 Q1	$30K	Sell	356 -16	-4%	-$1.75K	﹤0.01%	3772
2019 Q4	$44K	Buy	372 +318	+589%	+$27K	﹤0.01%	4024
2019 Q3	$3K	Sell	54 -104	-66%	-$7.67K	﹤0.01%	4732
2019 Q2	$9K	Buy	+158	New	+$16.8K	﹤0.01%	4995

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank's HOOK Position: Q2 2022 in Review

Deutsche Bank sold out of HOOKIPA Pharma (HOOK) in Q2 2022, closing a stake of 12,028 shares — an estimated $274K sold.

Deutsche Bank first reported a position in HOOK in Q2 2019 and held it in 12 quarters. The position peaked at $1.11M in Q2 2021. 58 funds tracked by Wall St. Rank hold HOOK as of Q2 2022.

Deutsche Bank reported no remaining HOOKIPA Pharma position as of Q2 2022 after selling out during the quarter.
Deutsche Bank sold 12,028 HOOKIPA Pharma shares in Q2 2022, an estimated $274K.
Deutsche Bank first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 12 quarters.
Deutsche Bank's HOOKIPA Pharma position peaked at $1.11M in Q2 2021.
58 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.